As filed with the Securities and Exchange Commission on August 9, 2023

Registration No. 333-

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

 

REGISTRATION STATEMENT

Under The Securities Act of 1933

 

OMEROS CORPORATION

(Exact name of Registrant as specified in its charter)

 

 

 

 

 

Washington

(State or other jurisdiction of

incorporation or organization)

91-1663741

(I.R.S. Employer

Identification Number)

201 Elliott Avenue West

Seattle, Washington 98119

(Address of principal executive offices) (Zip code)

 

 

Omeros Corporation 2017 Omnibus Incentive Compensation Plan

(Full title of the plan)

 

Gregory A. Demopulos, M.D.

President, Chief Executive Officer and

Chairman of the Board of Directors

Omeros Corporation

201 Elliott Avenue West

Seattle, Washington 98119

(Name and address of agent for service)

 

(206) 676-5000

(Telephone number, including area code, of agent for service)

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 under the Exchange Act.

 

 

 

 

 

 

 

 

 

Large accelerated filer

 

 

 

 

Accelerated filer

Non-accelerated filer

 

 

Smaller reporting company 

 

 

 

 

 

 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. 

 


REGISTRATION OF ADDITIONAL SECURITIES

PURSUANT TO GENERAL INSTRUCTION E

This registration statement registers 8,945,113 additional shares of common stock, par value $0.01 per share (the “Common Stock”), of Omeros Corporation (“we,” “us,” “our” or “Omeros”) to be issued pursuant to the Omeros Corporation 2017 Omnibus Incentive Compensation Plan, as amended and restated effective June 23, 2023. Accordingly, unless noted herein, the contents of our previous registration statements on Form S-8 filed with the United States Securities and Exchange Commission (the “SEC”) on June 21, 2017 (File No. 333-218882), June 11, 2019 (File No. 333-232071) and June 16, 2021 (File No. 333-257148) are incorporated by reference into this Registration Statement pursuant to General Instruction E of Form S-8.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.

Incorporation of Documents by Reference.

The following documents previously filed with the SEC (File No. 001-34475) are hereby incorporated by reference:

 

(a)

our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on March 13, 2023 and Amendment No. 1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on May 1, 2023;

 

(b)

all other reports we have filed with the SEC pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (other than the reports, or portions thereof, deemed to have been furnished and not filed with the SEC), since December 31, 2022; and

 

(c)

the description of our Common Stock contained in Exhibit 4.1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the SEC on March 1, 2021, including any amendments or reports filed for the purpose of updating such description.

All reports and other documents that we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act (other than Current Reports on Form 8-K furnished pursuant to Item 2.02 or Item 7.01 of Form 8-K, including any exhibits included with such information, unless otherwise indicated therein) prior to the filing of a post-effective amendment to this Registration Statement which states that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, but excluding any information furnished to, rather than filed with, the SEC (unless expressly incorporated by reference herein), will also be incorporated by reference into this Registration Statement and deemed to be part of this Registration Statement from the date of the filing of such reports and documents.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

Item 5.

Interests of Named Experts and Counsel.

The validity of the shares of Common Stock being registered under this Registration Statement has been passed upon by Keller Rohrback L.L.P., Seattle, Washington.

 


Item 8.

Exhibits.

Exhibit

Number

Exhibit Title

 

 

4.1

Amended and Restated Articles of Incorporation of Omeros Corporation (incorporated by reference from Exhibit 3.1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2009 (File No. 001-34475), filed on March 31, 2010).

 

 

4.2

Amended and Restated Bylaws of Omeros Corporation (incorporated by reference from Exhibit 3.2 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2009 (File No. 001-34475), filed on March 31, 2010).

 

 

4.3

Omeros Corporation 2017 Omnibus Incentive Compensation Plan (as amended and restated effective as of June 23, 2023) (incorporated by reference from Exhibit 10.1 to our Current Report on Form 8-K (File No. 001-34475), filed on June 28, 2023).

 

 

4.4

Form of Stock Option Award Agreement under the Omeros Corporation 2017 Omnibus Incentive Compensation Plan (incorporated by reference from Exhibit 4.4 to our Registration Statement on Form S-8 (File No. 333-218882), filed on June 21, 2017).

 

 

5.1*

Opinion of Keller Rohrback L.L.P.

 

 

23.1*

Consent of Independent Registered Public Accounting Firm.

 

 

23.2*

Consent of Keller Rohrback L.L.P. (included in Exhibit 5.1).

 

 

24.1*

Power of Attorney (included as part of the signature page to this Registration Statement).

107*

Filing Fee Table.

* Filed herewith

 

Item 9.

Undertakings.

The undersigned registrant hereby undertakes as set forth below.

1. To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the “Securities Act”);

(ii) to reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” in the effective registration statement; and

(iii) to include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement;


provided, however, that clauses (1)(i) and (1)(ii) do not apply if the information required to be included in a post-effective amendment by those clauses is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference into this registration statement.

2. That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

3. To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

4. That, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference into this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

5. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer, or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Seattle, State of Washington, on August 9, 2023.

 

 

 

 

OMEROS CORPORATION

 

 

By:

/s/ Gregory A. Demopulos, M.D. 

 

Gregory A. Demopulos, M.D.

President, Chief Executive Officer and Chairman of the Board of Directors

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Gregory A. Demopulos, M.D., Michael A. Jacobsen and Peter B. Cancelmo, and each of them severally, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

Signature

Title

Date

/s/ Gregory A. Demopulos, M.D.

President, Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer)

August 9, 2023

Gregory A. Demopulos, M.D.

/s/ Michael A. Jacobsen

Vice President, Finance, Chief Accounting Officer and Treasurer (Principal Financial and Accounting Officer)

August 9, 2023

Michael A. Jacobsen

/s/ Thomas F. Bumol, Ph.D.

Director

August 9, 2023

Thomas F. Bumol, Ph.D.

/s/ Thomas J. Cable

Director

August 9, 2023

Thomas J. Cable

/s/ Peter A. Demopulos, M.D.

Director

August 9, 2023

Peter A. Demopulos, M.D.


/s/ Arnold C. Hanish

Director

August 9, 2023

Arnold C. Hanish

/s/ Leroy E. Hood, M.D., Ph.D.

Director

August 9, 2023

Leroy E. Hood, M.D., Ph.D.

/s/ Diana T. Perkinson, M.D.

Director

August 9, 2023

Diana T. Perkinson, M.D.

/s/ Rajiv Shah, M.D.

Director

August 9, 2023

Rajiv Shah, M.D.


Exhibit 5.1

Keller Rohrback l.l.p.

August 9, 2023

Omeros Corporation

The Omeros Building

201 Elliott Avenue West

Seattle, WA 98119

Re:

Registration Statement on Form S-8.

Ladies and Gentlemen:

We have acted as Washington state counsel to you, Omeros Corporation, a Washington corporation (the “Company”), in connection with the registration under the Securities Act of 1933, as amended (the “Act”), of the offer and sale of an aggregate of 8,945,113 additional shares of the Company’s common stock, par value $0.01 per share (the “Shares”), reserved for issuance under the Omeros Corporation 2017 Omnibus Incentive Compensation Plan, as amended and restated effective as of June 23, 2023 (the “Plan”). In connection with rendering this opinion, we have examined such Plan and the registration statement on Form S-8 (the “Registration Statement”) to be filed by the Company with the Securities and Exchange Commission on or about the date hereof.

We have reviewed such other corporate records, certificates and documents and such questions of law as we have considered necessary or appropriate for the purpose of this opinion. We have assumed that all signatures are genuine, that all documents submitted to us as originals are authentic and that all copies of documents submitted to us conform to the originals. As to any facts material to our opinion, we have relied as to certain matters on information obtained from public officials, officers of the Company and other sources we believe to be responsible.

Based upon the foregoing, it is our opinion that the Shares have been duly authorized and, when issued in accordance with the terms of the Plan, will be validly issued, fully paid and nonassessable.

We are members of the bar of the State of Washington. We do not express any opinion herein on any laws other than the Washington Business Corporation Act, applicable provisions of the Washington State Constitution and reported judicial decisions interpreting these laws.

We hereby consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement and to the use of our name under the caption “Interests of Named Experts and Counsel” in the Registration Statement and any amendments thereto. In consenting to such reference, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Securities and Exchange Commission thereunder.

Very truly yours,

/s/ Keller Rohrback L.L.P.

KELLER ROHRBACK L.L.P.

1201 Third Avenue, Suite 3200, Seattle, WA 98101-3052 | Telephone: (206) 623-1900 | Facsimile: (206) 623-3384

Seattle (HQ)

Missoula

New York

Oakland

Phoenix

Portland

Santa Barbara

www.KellerRohrback.com | www.KRComplexLit.com


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Omeros Corporation 2017 Omnibus Incentive Compensation Plan of our reports dated March 13, 2023, with respect to the consolidated financial statements of Omeros Corporation, and the effectiveness of internal control over financial reporting of Omeros Corporation, included in its Annual Report (Form 10-K) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.

 

/s/ Ernst & Young LLP

Seattle, Washington

August 9, 2023


Exhibit 107

Calculation of Filing Fee Tables

Form S-8 

(Form Type)

OMEROS CORPORATION

(Exact Name of Registrant as Specified in its Charter)

Table 1:​ ​ Newly Registered Securities

 

 

 

 

 

 

 

 

 

Security Type

 

Security
Class

Title

 

Fee
Calculation
Rule

 

Amount
Registered

(1)(2)

 

Proposed
Maximum
Offering

Price Per

Unit (3)

 

Maximum

Aggregate

Offering

Price (3)

 

Fee

Rate

 

Amount of
Registration
Fee

 

 

 

 

 

 

 

 

Equity

 

Common Stock, par value $0.01 per share

 

Other

 

8,945,113

 

$4.04

 

$36,138,256.52

 

.0001102

 

$3,982.44

 

 

 

 

 

Total Offering Amounts

$36,138,256.52

$3,982.44

Total Fee Offsets

Net Fee Due

$3,982.44

(1)Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional shares of common stock, par value $0.01 per share, of Omeros Corporation (the “Company”) that become issuable under the Company’s 2017 Omnibus Incentive Compensation Plan, as amended and restated effective as of June 23, 2023 (as amended and restated, the “2017 Plan”), by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of the registrant’s common stock.

(2)The common stock being registered under this registration statement pertains to additional shares of common stock to be issued to employees, consultants, officers, advisors and/or directors as compensation under the 2017 Plan.

(3)The offering price is estimated in accordance with Rule 457(c) and 457(h) under the Securities Act solely for the purpose of calculating the registration fee based upon the price of $4.04 per share, which was the average of the high and low prices of the registrant’s common stock as reported on The Nasdaq Global Market on August 2, 2023.


Omeros (NASDAQ:OMER)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Omeros Charts.
Omeros (NASDAQ:OMER)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Omeros Charts.